FIELD: organic chemistry, medicine. SUBSTANCE: invention relates to compounds of the formula (I) where fragment (a) means groups of the formulas (b) or (c) and where W means free or substituted phenyl or 6-quinolinyl; y means a group C-R4; Z means C(R8)(R9); R3,R4,R5,R6,R8,R9 mean hydrogen. These compounds are highly active agonists, antagonists or reverse agonists of the brain GABA-receptors or prodrugs of agonists, antagonists or reverse agonists of the brain GABA-receptors. These compounds can be used for diagnosis and treatment of patients with neurosis, insomnia, epilepsy, at overdosing with drugs of benzodiazepine order and for memory improvement. EFFECT: new compounds indicated above, enhanced effectiveness of compounds. 24 cl, 5 dwg, 1 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
CONDENSED PYRROLE CARBOXANILIDES, NEW CLASS OF LIGANDS OF CEREBRAL GABA-RECEPTORS | 1994 |
|
RU2157367C2 |
NEW CONDENSED PYRROLE CARBOXYLIC ACID AMIDES: NOVEL CLASS OF LIGANDS OF BRAIN GABA-RECEPTORS | 1997 |
|
RU2167151C2 |
IMIDEAZOQUINOXALINES | 1992 |
|
RU2092487C1 |
ANELLATED CABAMOYLAZAHETEROCYCLES, FOCUSED LIBRARY, PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING | 2005 |
|
RU2281947C1 |
PYRAZOLO[3,4-C]PYRIDINE DERIVATIVES | 2015 |
|
RU2709810C2 |
ANELLATED CARBAMOYL AZAHETEROCYCLES, METHODS FOR THEIR PREPARING (VARIANTS), PHARMACEUTICAL COMPOSITION, FOCUSED LIBRARY | 2004 |
|
RU2266906C1 |
PROTEIN TYROSINE KINASE RECEPTOR INHIBITOR COMPOSITIONS | 2009 |
|
RU2586212C2 |
ISATINE OR ISATINE OXIME DERIVATIVES, METHOD OF SYNTHESIS OF ISATINE OXIME AND A PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2114827C1 |
NOVEL DIHYDRO-OXAZOLOBENZODIAZEPINE COMPOUNDS, METHOD OF OBTAINING THEREOF AND THEREOF-CONTAINING PHARMACEUTICAL COMPOSITIONS | 2012 |
|
RU2572556C2 |
PYRIMIDOBENZIMIDAZOLE DERIVATIVES AND APPLICATION THEREOF AS AGONISTS OR ANTAGONISTS OF MELANOCORTIN RECEPTORS | 2005 |
|
RU2392279C2 |
Authors
Dates
1999-02-10—Published
1994-10-26—Filed